MAKS PHARMACY LIMITED

Company Registration Number:
04691055 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

MAKS PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

MAKS PHARMACY LIMITED

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 464,414 474,036
Total fixed assets: 464,414 474,036
Current assets
Stocks: 48,569 59,632
Debtors:   173,161 169,838
Cash at bank and in hand: 21,405 4,092
Total current assets: 243,135 233,562
Creditors: amounts falling due within one year:   (365,625) (348,801)
Net current assets (liabilities): (122,490) (115,239)
Total assets less current liabilities: 341,924 358,797
Creditors: amounts falling due after more than one year:   (189,919) (231,755)
Total net assets (liabilities): 152,005 127,042
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 151,005 126,042
Shareholders funds: 152,005 127,042

The notes form part of these financial statements

MAKS PHARMACY LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 November 2025
and signed on behalf of the board by:

Name: Mr M A Makinde
Status: Director

The notes form part of these financial statements

MAKS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MAKS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 6 6

MAKS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 642,121
At 31 March 2025 642,121
Depreciation
At 01 April 2024 168,085
Charge for year 9,622
At 31 March 2025 177,707
Net book value
At 31 March 2025 464,414
At 31 March 2024 474,036